← Evidence map

ArticleBiomedical reports2021

Variant Philadelphia t(X;9;22)(q22?;q34;q11.2) can be successfully treated with second generation tyrosine kinase inhibitors: A case report and literature review.

Ana Iglesias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Variant Philadelphia t(X;9;22)(q22?;q34;q11.2) can be successfully treated with second generation tyrosine kinase inhibitors: A case report and literature review. | OpenQuestion